Biotest Aktiengesellschaft
Save
OverviewDividend safetyDividendsFundamentals
–
Market cap
–
Current P/E
–
Forward P/E

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas.

Similar securities

Based on sector and market capitalization

Mallinckrodt plc
XPhyto Therapeutics Corp.
Hologic Inc
Oncodesign Société Anonyme
Valneva SE
Esperite N.V.
Report issue